Lucentis Proves Effective Against Proliferative Diabetic Retinopathy
Friday, November 13, 2015 - 18:30
in Health & Medicine
A clinical trial among more than 300 patients has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that can severely damage eyesight.